Sokol H, Leducq V, Aschard H, Pham H, Jegou S, Landman C, Cohen D, Liguori G, Bourrier A, Nion-Larmurier I, Cosnes J, Seksik P, Langella P, Skurnik D, Richard M, Beaugerie L. Fungal microbiota dysbiosis in IBD. Gut. 2017;66(6):1039–48.
Article
CAS
PubMed
Google Scholar
Ren Z, Li A, Jiang J, Zhou L, Yu Z, Lu H, Xie H, Chen X, Shao L, Zhang R, Xu S, Zhang H, Cui G, Chen X, Sun R, Wen H, Lerut J, Kan Q, Li L, Zheng S. Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma. Gut. 2019;68(6):1014–23.
Article
CAS
PubMed
Google Scholar
Agus A, Clément K, Sokol H. Gut microbiota-derived metabolites as central regulators in metabolic disorders. Gut. 2021;70(6):1174–82.
Article
CAS
PubMed
Google Scholar
Kim B-R, Shin J, Guevarra RB, Lee JH, Kim DW, Seol K-H, Lee J-H, Kim HB, Isaacson RE. Deciphering diversity indices for a better understanding of microbial communities. J Microbiol Biotechnol. 2017;27(12):2089–93.
Article
PubMed
Google Scholar
Whiteson K, Bailey B, Bergkessel M, Conrad D, Delhaes L, Felts B, Harris J, Hunter R, Lim Y, Maughan H, Quinn R, Salamon P, Sullivan J, Wagner B, Rainey P. The upper respiratory tract as a microbial source for pulmonary infections in cystic fibrosis. Parallels from island biogeography. Am J Respir Crit Care Med. 2014;189(11):1309–15.
Article
PubMed
PubMed Central
Google Scholar
Man W, de Steenhuijsen Piters W, Bogaert D. The microbiota of the respiratory tract: gatekeeper to respiratory health. Nat Rev Microbiol. 2017;15(5):259–70.
Article
CAS
PubMed
PubMed Central
Google Scholar
Soriano JB, Kendrick PJ, Paulson KR, Gupta V, Abrams EM, Adedoyin RA, Adhikari TB, Advani SM, Agrawal A, Ahmadian E. Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet Respir Med. 2020;8(6):585–96.
Article
Google Scholar
Whiteside S, McGinniss J, Collman R. The lung microbiome: progress and promise. J Clin Invest. 2021;131(15): 150473.
Article
PubMed
Google Scholar
Cookson W, Cox M, Moffatt M. New opportunities for managing acute and chronic lung infections. Nat Rev Microbiol. 2018;16:111–20.
Article
CAS
PubMed
Google Scholar
Hutton B, Salanti G, Caldwell DM, Chaimani A, Schmid CH, Cameron C, Ioannidis JP, Straus S, Thorlund K, Jansen JP. The prisma extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med. 2015;162(11):777–84.
Article
PubMed
Google Scholar
Hutton B, Moher D, Cameron C. The prisma extension statement. Ann Intern Med. 2015;163(7):566–7.
Article
PubMed
Google Scholar
Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA. 2000;283(15):2008–12.
Article
CAS
PubMed
Google Scholar
McGrath S, Zhao X, Steele R, Thombs BD, Benedetti A, Collaboration DSDD. Estimating the sample mean and standard deviation from commonly reported quantiles in meta-analysis. Stat Methods Med Res. 2021;29(9):2520–37.
Article
Google Scholar
Deeks JJ, Higgins JPT, Altman DG (editors). Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editors. Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, 2022. Available from https://www.training.cochrane.org/handbook.
Viechtbauer W. Conducting meta-analyses in R with the metafor package. J Stat Softw. 2010;36(3):1–48.
Article
Google Scholar
Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–60.
Article
PubMed
PubMed Central
Google Scholar
Zintzaras E, Ioannidis JP. Heterogeneity testing in meta-analysis of genome searches. Genet Epidemiol. 2005;28(2):123–37.
Article
PubMed
Google Scholar
Audigier V, Husson F, Josse J. A principal component method to impute missing values for mixed data. Adv Data Anal Classif. 2016;10(1):5–26.
Article
Google Scholar
De Vito R, Bellio R, Trippa L, Parmigiani G. Multi-study factor analysis. Biometrics. 2019;75(1):337–46.
Article
PubMed
Google Scholar
Lee J-J, Kim S-H, Lee M-J, Kim B-K, Song W-J, Park H-W, Cho S-H, Hong S-J, Chang Y-S, Kim B-S. Different upper airway microbiome and their functional genes associated with asthma in young adults and elderly individuals. Allergy. 2018;74(4):709–19.
Article
PubMed
CAS
Google Scholar
Wang Z, Liu H, Wang F, Yang Y, Wang X, Chen B, Stampfli MR, Zhou H, Shu W, Brightling CE. A refined view of airway microbiome in chronic obstructive pulmonary disease at species and strain-levels. Front Microbiol. 2020;11:1758.
Article
PubMed
PubMed Central
Google Scholar
Cuthbertson L, Walker AW, Oliver AE, Rogers GB, Rivett DW, Hampton TH, Ashare A, Elborn JS, De Soyza A, Carroll MP. Lung function and microbiota diversity in cystic fibrosis. Microbiome. 2020;8(1):1–13.
Article
CAS
Google Scholar
Willner D, Furlan M, Haynes M, Schmieder R, Angly FE, Silva J, Tammadoni S, Nosrat B, Conrad D, Rohwer F. Metagenomic analysis of respiratory tract DNA viral communities in cystic fibrosis and non-cystic fibrosis individuals. PloS One. 2009;4(10):7370.
Article
CAS
Google Scholar
Jung J-W, Choi J-C, Shin J-W, Kim J-Y, Park I-W, Choi BW, Park H-W, Cho S-H, Kim K, Kang H-R. Lung microbiome analysis in steroid-naive asthma patients by using whole sputum. Tuberc Respir Dis. 2016;79(3):165.
Article
Google Scholar
Feigelman R, Kahlert CR, Baty F, Rassouli F, Kleiner RL, Kohler P, Brutsche MH, von Mering C. Sputum DNA sequencing in cystic fibrosis: non-invasive access to the lung microbiome and to pathogen details. Microbiome. 2017;5(1):1–14.
Article
Google Scholar
Filkins L, Hampton T, Gifford A, Gross M, Hogan D, Sogin M, Morrison H, Paster B, O’Toole G. Prevalence of streptococci and increased polymicrobial diversity associated with cystic fibrosis patient stability. J Bacteriol. 2012;194(17):4709–17.
Article
CAS
PubMed
PubMed Central
Google Scholar
Carmody LA, Zhao J, Schloss PD, Petrosino JF, Murray S, Young VB, Li JZ, LiPuma JJ. Changes in cystic fibrosis airway microbiota at pulmonary exacerbation. Ann Am Thorac Soc. 2013;10(3):179–87.
Article
PubMed
PubMed Central
Google Scholar
Goleva E, Jackson LP, Harris JK, Robertson CE, Sutherland ER, Hall CF, Good JT Jr, Gelfand EW, Martin RJ, Leung DY. The effects of airway microbiome on corticosteroid responsiveness in asthma. Am J Respir Crit Care Med. 2013;188(10):1193–201.
Article
CAS
PubMed
PubMed Central
Google Scholar
Denner DR, Sangwan N, Becker JB, Hogarth DK, Oldham J, Castillo J, Sperling AI, Solway J, Naureckas ET, Gilbert JA. Corticosteroid therapy and airflow obstruction influence the bronchial microbiome, which is distinct from that of bronchoalveolar lavage in asthmatic airways. J Allergy Clin Immunol. 2016;137(5):1398–405.
Article
CAS
PubMed
Google Scholar
Sverrild A, Kiilerich P, Brejnrod A, Pedersen R, Porsbjerg C, Bergqvist A, Erjefält JS, Kristiansen K, Backer V. Eosinophilic airway inflammation in asthmatic patients is associated with an altered airway microbiome. J Allergy Clin Immunol. 2017;140(2):407–17.
Article
PubMed
Google Scholar
Liu H-Y, Li C-X, Liang Z-Y, Zhang S-Y, Yang W-Y, Ye Y-M, Lin Y-X, Chen R-C, Zhou H-W, Su J. The interactions of airway bacterial and fungal communities in clinically stable asthma. Front Microbiol. 2020;11:1647.
Article
PubMed
PubMed Central
Google Scholar
Li N, Qiu R, Yang Z, Li J, Chung KF, Zhong N, Zhang Q. Sputum microbiota in severe asthma patients: relationship to eosinophilic inflammation. Respir Med. 2017;131:192–8.
Article
CAS
PubMed
Google Scholar
Marri PR, Stern DA, Wright AL, Billheimer D, Martinez FD. Asthma-associated differences in microbial composition of induced sputum. J Allergy Clin Immunol. 2013;131(2):346–52.
Article
CAS
PubMed
Google Scholar
Huang C, Yu Y, Du W, Liu Y, Dai R, Tang W, Wang P, Zhang C, Shi G. Fungal and bacterial microbiome dysbiosis and imbalance of trans-kingdom network in asthma. Clin Transl Allergy. 2020;10(1):1–13.
Article
CAS
Google Scholar
Munck C, Helby J, Westergaard CG, Porsbjerg C, Backer V, Hansen LH. Smoking cessation and the microbiome in induced sputum samples from cigarette smoking asthma patients. PloS One. 2016;11(7):0158622.
Article
CAS
Google Scholar
Park H, Shin JW, Park S-G, Kim W. Microbial communities in the upper respiratory tract of patients with asthma and chronic obstructive pulmonary disease. PloS One. 2014;9(10): 109710.
Article
CAS
Google Scholar
Erb-Downward JR, Thompson DL, Han MK, Freeman CM, McCloskey L, Schmidt LA, Young VB, Toews GB, Curtis JL, Sundaram B. Analysis of the lung microbiome in the “healthy’’ smoker and in COPD. PloS One. 2011;6(2):16384.
Article
CAS
Google Scholar
Pragman AA, Kim HB, Reilly CS, Wendt C, Isaacson RE. The lung microbiome in moderate and severe chronic obstructive pulmonary disease. PloS One. 2012;7(10):47305.
Article
CAS
Google Scholar
Einarsson G, Comer D, McIlreavey L, Parkhill J, Ennis M, Tunney M, Elborn J. Community dynamics and the lower airway microbiota in stable chronic obstructive pulmonary disease, smokers and healthy non-smokers. Thorax. 2016;71(9):795–803.
Article
CAS
PubMed
Google Scholar
Kim HJ, Kim Y-S, Kim K-H, Choi J-P, Kim Y-K, Yun S, Sharma L, Cruz CSD, Lee JS, Oh Y-M. The microbiome of the lung and its extracellular vesicles in nonsmokers, healthy smokers and COPD patients. Exp Mol Med. 2017;49(4):316–316.
Article
CAS
Google Scholar
Millares L, Pérez-Brocal V, Ferrari R, Gallego M, Pomares X, Garcia-Nunez M, Monton C, Capilla S, Monso E, Moya A. Functional metagenomics of the bronchial microbiome in COPD. PloS One. 2015;10(12):0144448.
Article
CAS
Google Scholar
Pletcher SD, Goldberg AN, Cope EK. Loss of microbial niche specificity between the upper and lower airways in patients with cystic fibrosis. Laryngoscope. 2019;129(3):544–50.
Article
PubMed
Google Scholar
Soret P, Vandenborght L-E, Francis F, Coron N, Enaud R, Avalos M, Schaeverbeke T, Berger P, Fayon M, Thiebaut R. Respiratory mycobiome and suggestion of inter-kingdom network during acute pulmonary exacerbation in cystic fibrosis. Sci Rep. 2020;10(1):1–14.
Article
CAS
Google Scholar
Narayanamurthy V, Sweetnam JM, Denner DR, Chen LW, Naureckas ET, Laxman B, White SR. The metabolic footprint of the airway bacterial community in cystic fibrosis. Microbiome. 2017;5(1):1–11.
Article
Google Scholar
Coburn B, Wang PW, Caballero JD, Clark ST, Brahma V, Donaldson S, Zhang Y, Surendra A, Gong Y, Tullis DE. Lung microbiota across age and disease stage in cystic fibrosis. Sci Rep. 2015;5(1):1–12.
Article
CAS
Google Scholar
Byun MK, Chang J, Kim HJ, Jeong SH. Differences of lung microbiome in patients with clinically stable and exacerbated bronchiectasis. PLoS One. 2017;12(8):0183553.
Article
CAS
Google Scholar
Huang Y, Boushey H. The sputum microbiome in chronic obstructive pulmonary disease exacerbations. Ann Am Thorac Soc Suppl. 2015;2:176–80.
Article
Google Scholar
Tangedal S, Nielsen R, Aanerud M, Persson L, Wiker H, Bakke P, Hiemstra P, Eagan T. Sputum microbiota and inflammation at stable state and during exacerbations in a cohort of chronic obstructive pulmonary disease (COPD) patients. PLoS One. 2019;14(9):0222449.
Article
CAS
Google Scholar
Vandenborght LE, Enaud R, Urien C, Coron N, Girodet PO, Ferreira S, Berger P, Delhaes L. Type 2-high asthma is associated with a specific indoor mycobiome and microbiome. J Allergy Clin Immunol. 2021;147(4):1296–305.
Article
CAS
PubMed
Google Scholar
Mathieu E, Escribano-Vazquez U, Descamps D, Cherbuy C, Langella P, Riffault S, Remot A, Thomas M. Paradigms of lung microbiota functions in health and disease, particularly, in asthma. Front Physiol. 2018;9:1168.
Article
PubMed
PubMed Central
Google Scholar
Yagi K, Huffnagle G, Lukacs N, Asai N. The lung microbiome during health and disease. Int J Mol Sci. 2021;22(19):10872.
Article
CAS
PubMed
PubMed Central
Google Scholar
Soler X, Ramsdell J. Are asthma and copd a continuum of the same disease? J Allergy Clin Immunol Pract. 2015;3(4):489–95.
Article
PubMed
Google Scholar
Metzger M, Graeber S, Stahl M, Sommerburg O, Mall M, Dalpke A, Boutin S. A volatile and dynamic longitudinal microbiome is associated with less reduction in lung function in adolescents with cystic fibrosis. Front Cell Infect Microbiol. 2021;11: 763121.
Article
CAS
PubMed
PubMed Central
Google Scholar
Dicker A, Huang J, Lonergan M, Keir H, Fong C, Tan B, Cassidy A, Finch S, Mullerova H, Miller B, Tal-Singer R, Chalmers J. The sputum microbiome, airway inflammation, and mortality in chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2021;147(1):158–67.
Article
CAS
PubMed
Google Scholar
Johnson K, Burnet P. Microbiome: should we diversify from diversity? Gut Microbes. 2016;7:455–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wilkins L, Monga M, Miller A. Defining dysbiosis for a cluster of chronic diseases. Sci Rep. 2019. https://doi.org/10.1038/s41598-019-49452-y.
Article
PubMed
PubMed Central
Google Scholar
Priya S, Blekhman R. Population dynamics of the human gut microbiome: change is the only constant. Genome Biol 2019. 10.1186/s13059-019-1775-3
Chiarello M, McCauley M, Villeger S, Jackson C. Ranking the biases: the choice of OTUS vs. ASVS in 16s rRNA amplicon data analysis has stronger effects on diversity measures than rarefaction and OTU identity threshold. PLoS ONE. 2022;17(2):0264443.
Article
CAS
Google Scholar
Rogers G, Bruce K, Martin M, Burr L, Serisier D. The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial. Lancet Respir Med. 2014;2(12):988–96.
Article
CAS
PubMed
Google Scholar
Mac Aog áin M, Chandrasekaran R, Lim A, Low T, Tan G, Hassan T, Ong T, Hui Qi Ng A, Bertrand D, Koh J, Pang S, Lee Z, Gwee X, Martinus C, Sio Y, Matta S, Chew F, Keir H, Connolly J, Abisheganaden J, Koh M, Nagarajan N, Chalmers J, Chotirmall S. Immunological corollary of the pulmonary mycobiome in bronchiectasis: the CAMEB study. Eur Respir J. 2018; 52(1), 1800766
Mac Aog áin M, Narayana J, Tiew P, Ali N, Yong V, Jaggi T, Lim A, Keir H, Dicker A, Thng K, Tsang A, Ivan F, Poh M, Oriano M, Aliberti S, Blasi F, Low T, Ong T, Oliver B, Giam Y, Tee A, Koh M, Abisheganaden J, Tsaneva-Atanasova K, Chalmers J, Chotirmall S. Integrative microbiomics in bronchiectasis exacerbations. Nat Med. 2021; 27(4), 688–699.
Abdel-Aziz MI, Brinkman P, Vijverberg S, Neerincx A, Riley J, Bates S, Hashimoto S, Kermani N, Chung K, Djukanovic R, Dahlén S, Adcock I, Howarth P, Sterk P, Kraneveld A, Maitland-van der Zee, A, U-BIOPRED Study Group: Sputum microbiome profiles identify severe asthma phenotypes of relative stability at 12 to 18 months. J Allergy Clin Immunol. 2021; 147(1), 123–134.